Literature DB >> 28755254

Looking for the Good, Bad and the Ugly rectal cancers of the twenty-first century… or "How to avoid tears when peeling onions".

R Glynne-Jones1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28755254     DOI： 10.1007/s10151-017-1661-5

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  20 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?

Authors:  Angelita Habr-Gama; Jorge Sabbaga; Joaquim Gama-Rodrigues; Guilherme P São Julião; Igor Proscurshim; Patricia Bailão Aguilar; Wladimir Nadalin; Rodrigo O Perez
Journal:  Dis Colon Rectum       Date:  2013-10       Impact factor: 4.585

3.  Chemotherapy with preoperative radiotherapy in rectal cancer.

Authors:  Jean-François Bosset; Laurence Collette; Gilles Calais; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Alain Daban; Etienne Bardet; Alexander Beny; Jean-Claude Ollier
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

4.  Improved survival with preoperative radiotherapy in resectable rectal cancer.

Authors:  B Cedermark; M Dahlberg; B Glimelius; L Påhlman; L E Rutqvist; N Wilking
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

5.  International consensus guidelines on Clinical Target Volume delineation in rectal cancer.

Authors:  Vincenzo Valentini; Maria Antonietta Gambacorta; Brunella Barbaro; Giuditta Chiloiro; Claudio Coco; Prajnan Das; Francesco Fanfani; Ines Joye; Lisa Kachnic; Philippe Maingon; Corrie Marijnen; Samuel Ngan; Karin Haustermans
Journal:  Radiother Oncol       Date:  2016-08-12       Impact factor: 6.280

6.  Baseline T Classification Predicts Early Tumor Regrowth After Nonoperative Management in Distal Rectal Cancer After Extended Neoadjuvant Chemoradiation and Initial Complete Clinical Response.

Authors:  Angelita Habr-Gama; Guilherme Pagin São Julião; Joaquim Gama-Rodrigues; Bruna Borba Vailati; Cinthia Ortega; Laura Melina Fernandez; Sérgio Eduardo Alonso Araújo; Rodrigo Oliva Perez
Journal:  Dis Colon Rectum       Date:  2017-06       Impact factor: 4.585

7.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Authors:  Jean-Pierre Gérard; Thierry Conroy; Franck Bonnetain; Olivier Bouché; Olivier Chapet; Marie-Thérèse Closon-Dejardin; Michel Untereiner; Bernard Leduc; Eric Francois; Jean Maurel; Jean-François Seitz; Bruno Buecher; Rémy Mackiewicz; Michel Ducreux; Laurent Bedenne
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

8.  Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score.

Authors:  Nick J Battersby; George Bouliotis; Katrine J Emmertsen; Therese Juul; Rob Glynne-Jones; Graham Branagan; Peter Christensen; Søren Laurberg; Brendan J Moran
Journal:  Gut       Date:  2017-01-23       Impact factor: 23.059

9.  Chronic pain in the pelvic area or lower extremities after rectal cancer treatment and its impact on quality of life: a population-based cross-sectional study.

Authors:  Marie-Louise Feddern; Troels Staehelin Jensen; Søren Laurberg
Journal:  Pain       Date:  2015-09       Impact factor: 6.961

10.  Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

Authors:  Mark S Roh; Linda H Colangelo; Michael J O'Connell; Greg Yothers; Melvin Deutsch; Carmen J Allegra; Morton S Kahlenberg; Luis Baez-Diaz; Carol S Ursiny; Nicholas J Petrelli; Norman Wolmark
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.